Use of BCG as an immunostimulant in the surgical treatment of carcinoma of lung: a five-year follow-up report.
Sixty consecutive surviving patients treated with subdermal BCG (5 X 10(6) organisms) have been followed up for five years after resection of lung carcinoma. A control group of the previous 60 consecutive surviving patients not treated with BCG was similarly studied. We found no statistical evidence...
Guardat en:
| Publicat a: | Thorax |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1978
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC470878/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/663885/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.33.2.250 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|